Home Add to Favorite Contact Submit  
           28 February, 2020

Category:  Press

 » Health & Fitness


Press releases Records 351-351 of 351  |  Go to << Prior 1 ... 34 35 36 page 
Order by  Date Added  |  Popularity  |  Alphabet
Corgentech Pain Drug, 4975, Demonstrates Statistically Significant Pain Reduction After Knee Replacement Surgeries (Popularity: )
Corgentech Inc. (Nasdaq: CGTK) today reported positive, top-line clinical data from a Phase 2 clinical trial in total knee replacement surgeries showing that 4975, the company's novel, long-acting, non-opioid drug candidate being developed for site-specific, moderate-to-severe pain, demonstrated pain reduction at all pre-specified time intervals in the study, including statistically significant pain relief at day one (p=0.0273) and at day 14 (p=0.0071). The difference in average daily pain scores between ...